Xenocor
Private Company
Funding information not available
Overview
Xenocor is a private, commercial-stage medical device company focused on revolutionizing laparoscopic surgery with its single-use, high-definition Saberscope™ system. The company has closed a Series A funding round and is bringing its product to market, targeting hospitals and surgical centers with a value proposition centered on improved clinical outcomes, cost efficiency, and infection control. Led by a team with medical and operational expertise, Xenocor is positioned in the growing single-use medical device market but faces competition from established reusable scope manufacturers and must drive widespread surgeon adoption.
Technology Platform
Single-use, integrated HD laparoscopic imaging system (Saberscope™) with plug-and-play connectivity.
Opportunities
Risk Factors
Competitive Landscape
Xenocor competes directly with major medical device companies that dominate the reusable laparoscopic scope market (e.g., Stryker, Medtronic, Olympus). Its differentiation is the single-use, integrated HD model. Competition also includes other single-use scope startups, though Xenocor claims an industry-first with its 1080p HD capability in a disposable.